Skip to main content
SpringerLink
Log in
Book cover

The Vascular Endothelium I pp 295–329Cite as

Endothelin

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 176/I))

Abstract

In humans, the endothelins (ETs) comprise a family of three 21-amino-acid peptides, ET-1, ET-2 and ET-3. ET-1 is synthesised from a biologically inactive precursor, Big ET-1, by an unusual hydrolysis of the Trp21-Val22 bond by the endothelin converting enzyme (ECE-1). In humans, there are four isoforms (ECE-1a-d) derived from a single gene by the action of alternative promoters. Structurally, they differ only in the amino acid sequence of the extreme N-terminus. A second enzyme, ECE-2, also exists as four isoforms and differs from ECE-1 in requiring an acidic pH for optimal activity. Human chymase can also cleave Big ET-1 to ET-11–31, which is cleaved, in turn, to the mature peptide as an alternative pathway. ET-1 is the principal isoform in the human cardiovascular system and remains one of the most potent constrictors of human vessels discovered. ET-1 is unusual in being released from a dual secretory pathway. The peptide is continuously released from vascular endothelial cells by the constitutive pathway, producing intense constriction of the underlying smooth muscle and contributing to the maintenance of endogenous vascular tone. ET-1 is also released from endothelial cell-specific storage granules (Weibel-Palade bodies) in response to external stimuli. ETs mediate their action by activating two G protein-coupled receptor sub-types, ETA and ETB. Two therapeutic strategies have emerged to oppose the actions of ET-1, namely inhibition of the synthetic enzyme by combined ECE/neutral endopeptidase inhibitors such as SLV306, and receptor antagonists such as bosentan. The ET system is up-regulated in atherosclerosis, and ET antagonists may be of benefit in reducing blood pressure in essential hypertension. Bosentan, the first ET antagonist approved for clinical use, represents a significant new therapeutic strategy in the treatment of pulmonary arterial hypertension (PAH).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adachi M, Yang YY, Furuichi Y, Miyamoto C (1991) Cloning and characterization of cDNA encoding human A-type endothelin receptor. Biochem Biophys Res Commun 180:1265–1272

    PubMed  CAS  Google Scholar 

  • Adner M, Jansen I, Edvinsson L (1994) Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst 49Suppl:S117–121

    PubMed  CAS  Google Scholar 

  • Adner M, Cardell LO, Sjoberg T, Ottosson A, Edvinsson L (1996) Contractile endothelin-B (ETB) receptors in human small bronchi. Eur Respir J 9:351–355

    PubMed  CAS  Google Scholar 

  • Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–7322

    PubMed  CAS  Google Scholar 

  • Aramori I, Nirei H, Shoubo M, Sogabe K, Nakamura K, Kojo H, Notsu Y, Ono T, Nakanishi S (1993) Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol Pharmacol 43:127–131

    PubMed  CAS  Google Scholar 

  • Ashby MJ, Plumpton C, Teale P, Kuc RE, Houghton E, Davenport AP (1995) Analysis of endogenous human endothelin peptides by high-performance liquid chromatography and mass spectrometry. J Cardiovasc Pharmacol 26Suppl 3:S247–249

    PubMed  CAS  Google Scholar 

  • Bacon CR, Davenport AP (1996) Endothelin receptors in human coronary artery and aorta. Br J Pharmacol 117:986–992

    PubMed  CAS  Google Scholar 

  • Bacon CR, Cary NR, Davenport AP (1995) Distribution of endothelin receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 26Suppl 3:439–444

    Google Scholar 

  • Bacon CR, Cary NR, Davenport AP (1996) Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res 79:794–801

    PubMed  CAS  Google Scholar 

  • Balwierczak JL, Bruseo CW, DelGrande D, Jeng AY, Savage P, Shetty SS (1995) Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500. J Cardiovasc Pharmacol 26Suppl 3:S393–396

    PubMed  CAS  Google Scholar 

  • Barnes K, Shimada K, Takahashi M, Tanzawa K, Turner AJ (1996) Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J Cell Sci 109:919–928

    PubMed  CAS  Google Scholar 

  • Barnes K, Brown C, Turner AJ (1998) Endothelin-converting enzyme: ultrastructural localization and its recycling from the cell surface. Hypertension 31:3–9

    PubMed  CAS  Google Scholar 

  • Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277–1285

    PubMed  CAS  Google Scholar 

  • Bourgeois C, Robert B, Rebourcet R, Mondon F, Mignot TM, Duc-Goiran P, Ferre F (1997) Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3. J Clin Endocrinol Metab 82:3116–3123

    PubMed  CAS  Google Scholar 

  • Campia U, Cardillo C, Panza JA (2004) Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation 109:3191–3195

    PubMed  Google Scholar 

  • Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ (2001) Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358:1119–1123

    PubMed  CAS  Google Scholar 

  • Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada M, Hammer RE, Yanagisawa M (1998) Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813–824

    PubMed  CAS  Google Scholar 

  • Clozel M, Breu V (1996) The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443. FEBS Lett 383:42–45

    PubMed  CAS  Google Scholar 

  • Clozel M, Salloukh H (2005) Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Ann Med 37:2–12

    PubMed  CAS  Google Scholar 

  • Cohn JN (1996) Is there a role for endothelin in the natural history of heart failure? Circulation 94:604–606

    PubMed  CAS  Google Scholar 

  • D’Orleans-Juste P, Plante M, Honore JC, Carrier E, Labonte J (2003) Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol 81:503–510

    PubMed  CAS  Google Scholar 

  • Dagassan PH, Breu V, Clozel M, Kunzli A, Vogt P, Turina M, Kiowski W, Clozel JP (1996) Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 27:147–153

    PubMed  CAS  Google Scholar 

  • Davenport A (1997) Distribution of endothelin receptors. In: Huggins JP, Pelton JT (eds) Endothelin in biology and medicine. CRC Press, New York, pp 45–68

    Google Scholar 

  • Davenport AP (2002) International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54:219–226

    PubMed  CAS  Google Scholar 

  • Davenport AP, Battistini B (2002) Classification of endothelin receptors and antagonists in clinical development. Clin Sci (Lond) 103Suppl 48:1S–3S

    PubMed  CAS  Google Scholar 

  • Davenport AP, Kuc RE (2000) Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. J Cardiovasc Pharmacol 36:S12–14

    PubMed  CAS  Google Scholar 

  • Davenport AP, Maguire JJ (1994) Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci 15:9–11

    PubMed  CAS  Google Scholar 

  • Davenport AP, Maguire JJ (2002) Of mice and men: advances in endothelin research and first antagonist gains FDA approval. Trends Pharmacol Sci 23:155–157

    PubMed  CAS  Google Scholar 

  • Davenport AP, Russell FD (2001) Endothelin converting enzymes and endothelin receptor localisation in human tissues. In: Warner TD (ed) Endothelin and its inhibitors. (Handbook of experimental pharmacology, vol 152) Springer, Heidelberg Berlin New York, pp 209–237

    Google Scholar 

  • Davenport AP, Nunez DJ, Hall JA, Kaumann AJ, Brown MJ (1989) Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol 13Suppl 5:S166–S170

    PubMed  CAS  Google Scholar 

  • Davenport AP, O’Reilly G, Molenaar P, Maguire JJ, Kuc RE, Sharkey A, Bacon CR, Ferro A (1993) Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 22Suppl 8:S22–25

    PubMed  CAS  Google Scholar 

  • Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM (1994) [125I]-PD151242: a selective radioligand for human ETA receptors. Br J Pharmacol 111:4–6

    PubMed  CAS  Google Scholar 

  • Davenport AP, Kuc RE, Maguire JJ, Harland SP (1995a) ETA receptors predominate in the human vasculature and mediate constriction. J Cardiovasc Pharmacol 26Suppl 3:S265–267

    PubMed  CAS  Google Scholar 

  • Davenport AP, O’Reilly G, Kuc RE (1995b) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol 114:1110–1116

    PubMed  CAS  Google Scholar 

  • Davenport AP, Hoskins SL, Kuc RE, Plumpton C (1996) Differential distribution of endothelin peptides and receptors in human adrenal gland. Histochem J 28:779–789

    PubMed  CAS  Google Scholar 

  • Davenport AP, Kuc RE, Mockridge JW (1998a) Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells. J Cardiovasc Pharmacol 31Suppl 1:S1–3

    PubMed  CAS  Google Scholar 

  • Davenport AP, Kuc RE, Plumpton C, Mockridge JW, Barker PJ, Huskisson NS (1998b) Endothelin-converting enzyme in human tissues. Histochem J 30:359–374

    CAS  Google Scholar 

  • Davenport AP, Kuc RE, Ashby MJ, Patt WC, Doherty AM (1998c) Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues. Br J Pharmacol 123:223–230

    PubMed  CAS  Google Scholar 

  • Docherty JC, Gunter HE, Kuzio B, Shoemaker L, Yang L, Deslauriers R (1997) Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies. J Mol Cell Cardiol 29:1665–1673

    PubMed  CAS  Google Scholar 

  • Doherty AM, Patt WC, Edmunds JJ, Berryman KA, Reisdorph BR, Plummer MS, Shahripour A, Lee C, Cheng XM, Walker DM, et al (1995) Discovery of a novel series of orally active non-peptide endothelin-A (ETA) receptor-selective antagonists. J Med Chem 38:1259–1263

    PubMed  CAS  Google Scholar 

  • Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB (2003) Alzheimer’s disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278:2081–2084

    PubMed  CAS  Google Scholar 

  • Emoto N, Yanagisawa M (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262–15268

    PubMed  CAS  Google Scholar 

  • Flynn MA, Haleen SJ, Welch KM, Cheng XM, Reynolds EE (1998) Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology. J Cardiovasc Pharmacol 32:106–116

    PubMed  CAS  Google Scholar 

  • Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279–288

    PubMed  CAS  Google Scholar 

  • Fukuroda T, Kobayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K, Nishikibe M (1994) Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 76:1976–1982

    PubMed  CAS  Google Scholar 

  • Gajkowska B, Mossakowski MJ (1995) Localization of endothelin in the blood-brain interphase in rat hippocampus after global cerebral ischemia. Folia Neuropathol 33:221–230

    PubMed  CAS  Google Scholar 

  • Gasic S, Wagner OF, Vierhapper H, Nowotny P, Waldhausl W (1992) Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J Cardiovasc Pharmacol 19:176–180

    PubMed  CAS  Google Scholar 

  • Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, Masaki T, Ibrahim NB, Roberts GW, Rossi ML, et al (1991) Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 95:303–314

    PubMed  CAS  Google Scholar 

  • Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ (2004) Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation 109:1186–1193

    PubMed  CAS  Google Scholar 

  • Gui G, Xu D, Emoto N, Yanagisawa M (1993) Intracellular localization of membrane-bound endothelin-converting enzyme from rat lung. J Cardiovasc Pharmacol 22Suppl 8:S53–56

    PubMed  CAS  Google Scholar 

  • Hai E, Ikura Y, Naruko T, Shirai N, Yoshimi N, Kayo S, Sugama Y, Fujino H, Ohsawa M, Tanzawa K, Yokota T, Ueda M (2004) Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis. Int J Mol Med 13:649–654

    PubMed  CAS  Google Scholar 

  • Hardebo JE, Kahrstrom J, Owman C, Salford LG (1989) Endothelin is a potent constrictor of human intracranial arteries and veins. Blood Vessels 26:249–253

    PubMed  CAS  Google Scholar 

  • Harland SP, Kuc RE, Pickard JD, Davenport AP (1995) Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol 26Suppl 3:S408–411

    PubMed  CAS  Google Scholar 

  • Harland SP, Kuc RE, Pickard JD, Davenport AP (1998) Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 43:890–898; discussion 898–899

    PubMed  CAS  Google Scholar 

  • Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR (1995) Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A 92:6344–6348

    PubMed  CAS  Google Scholar 

  • Hay DW, Henry PJ, Goldie RG (1993) Endothelin and the respiratory system. Trends Pharmacol Sci 14:29–32

    PubMed  CAS  Google Scholar 

  • Hay DW, Luttmann MA, Pullen MA, Nambi P (1998) Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype? J Pharmacol Exp Ther 284:669–677

    PubMed  CAS  Google Scholar 

  • Haynes WG, Webb DJ (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344:852–854

    PubMed  CAS  Google Scholar 

  • Haynes WG, Hand MF, Johnstone HA, Padfield PL, Webb DJ (1994) Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. J Clin Invest 94:1359–1364

    PubMed  CAS  Google Scholar 

  • Haynes WG, Strachan FE, Webb DJ (1995) Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92:357–363

    PubMed  CAS  Google Scholar 

  • Haynes WG, Ferro CJ, O’Kane KP, Somerville D, Lomax CC, Webb DJ (1996) Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93:1860–1870

    PubMed  CAS  Google Scholar 

  • Hemsen A, Gillis C, Larsson O, Haegerstrand A, Lundberg JM (1991) Characterization, localization and actions of endothelins in umbilical vessels and placenta of man. Acta Physiol Scand 143:395–404

    PubMed  CAS  Google Scholar 

  • Henry PJ, Rigby PJ, Self GJ, Preuss JM, Goldie RG (1990) Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol 100:786–792

    PubMed  CAS  Google Scholar 

  • Hickey KA, Rubanyi G, Paul RJ, Highsmith RF (1985) Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 248:C550–556

    PubMed  CAS  Google Scholar 

  • Hocher B, Dembowski C, Slowinski T, Friese ST, Schwarz A, Siren AL, Neumayer HH, Thone-Reineke C, Bauer C, Nafz B, Ehrenreich H (2001) Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med 78:633–641

    PubMed  CAS  Google Scholar 

  • Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M (1994) Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267–1276

    PubMed  CAS  Google Scholar 

  • Howard PG, Plumpton C, Davenport AP (1992) Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 10:1379–1386

    PubMed  CAS  Google Scholar 

  • Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M (1992a) Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50:247–255

    PubMed  CAS  Google Scholar 

  • Ihara M, Saeki T, Fukuroda T, Kimura S, Ozaki S, Patel AC, Yano M (1992b) A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors. Life Sci 51:PL47–52

    PubMed  CAS  Google Scholar 

  • Ihara M, Yamanaka R, Ohwaki K, Ozaki S, Fukami T, Ishikawa K, Towers P, Yano M (1995) [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. Eur J Pharmacol 274:1–6

    PubMed  CAS  Google Scholar 

  • Ikeda S, Emoto N, Alimsardjono H, Yokoyama M, Matsuo M (2002) Molecular isolation and characterization of novel four subisoforms of ECE-2. Biochem Biophys Res Commun 293:421–426

    PubMed  CAS  Google Scholar 

  • Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86:2863–2867

    PubMed  CAS  Google Scholar 

  • Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, et al (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91:4892–4896

    PubMed  CAS  Google Scholar 

  • Janes RW, Peapus DH, Wallace BA (1994) The crystal structure of human endothelin. Nat Struct Biol 1:311–319

    PubMed  CAS  Google Scholar 

  • Johnström P, Fryer TD, Richards HK, Harris NG, Barret O, Clark JC, Pickard JD, Davenport AP (2005) Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol 144:115–122

    PubMed  Google Scholar 

  • Kalogeropoulou K, Mortzos G, Migdalis I, Velentzas C, Mikhailidis DP, Georgiadis E, Cordopatis P (2002) Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin. Angiology 53:279–285

    PubMed  CAS  Google Scholar 

  • Karet FE, Davenport AP (1993) Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. J Cardiovasc Pharmacol 22Suppl 8:S29–33

    PubMed  CAS  Google Scholar 

  • Karet FE, Davenport AP (1996) Localization of endothelin peptides in human kidney. Kidney Int 49:382–387

    PubMed  CAS  Google Scholar 

  • Karet FE, Kuc RE, Davenport AP (1993) Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int 44:36–42

    PubMed  CAS  Google Scholar 

  • Katugampola SD, Davenport AP (2002) Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. Clin Sci (Lond) 102:15–21

    PubMed  CAS  Google Scholar 

  • Katugampola SD, Kuc RE, Maguire JJ, Davenport AP (2002) G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized. Clin Sci (Lond) 2002 103Suppl 48:171S–175S

    CAS  Google Scholar 

  • Kelland NF, Bagnall AJ, Gulliver-Sloan FH, Kuc RE, Maguire JJ, Davenport AP, Gray GA, Kotelevtsev YV, Webb DJ (2004) Clearance of circulating endothelin-1 is mediated by the endothelial cell endothelin B receptor. http://www.pa2online.org/Vol2Issue4abst022P.html.

    Google Scholar 

  • Kiowski W, Luscher TF, Linder L, Buhler FR (1991) Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83:469–475

    PubMed  CAS  Google Scholar 

  • Knott PG, D’Aprile AC, Henry PJ, Hay DW, Goldie RG (1995) Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol 114:1–3

    PubMed  CAS  Google Scholar 

  • Kuc RE, Davenport AP (2000) Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels of endothelin-1? J Cardiovasc Pharmacol 36:S377–379

    PubMed  CAS  Google Scholar 

  • Kuc RE, Karet FE, Davenport AP (1995) Characterization of peptide and nonpeptide antagonists in human kidney. J Cardiovasc Pharmacol 26Suppl 3:S373–375

    PubMed  CAS  Google Scholar 

  • Kurihara H, Kurihara Y Yazaki Y (2001) Lessons from gene deletion in the endothelin system. In: Warner TD (ed) Endothelin and its inhibitors. (Handbook of experimental pharmacology, vol 152) Springer, Heidelberg Berlin New York, pp 141–154

    Google Scholar 

  • Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, et al (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703–710

    PubMed  CAS  Google Scholar 

  • Kurnik D, Haviv Y, Kochva E (1999) A snake bite by the burrowing asp, Atractaspis engaddensis. Toxicon 37:223–227

    PubMed  CAS  Google Scholar 

  • Langlois C, Letourneau M, Lampron P, St-Hilaire V, Fournier A (2003) Development of agonists of endothelin-1 exhibiting selectivity towards ETA receptors. Br J Pharmacol 139:616–622

    PubMed  CAS  Google Scholar 

  • Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997–1001

    PubMed  CAS  Google Scholar 

  • Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr (1995) Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92:2426–2431

    PubMed  CAS  Google Scholar 

  • Lin HY, Kaji EH, Winkel GK, Ives HE, Lodish HF (1991) Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci U S A 88:3185–3189

    PubMed  CAS  Google Scholar 

  • Liu JJ, Chen JR, Buxton BF (1996) Unique response of human arteries to endothelin B receptor agonist and antagonist. Clin Sci (Lond) 90:91–96

    PubMed  CAS  Google Scholar 

  • Lucas GA, White LR, Juul R, Cappelen J, Aasly J, Edvinsson L (1996) Relaxation of human temporal artery by endothelin ETB receptors. Peptides 17:1139–1144

    PubMed  CAS  Google Scholar 

  • Ma KC, Nie XJ, Hoog A, Olsson Y, Zhang WW (1994) Reactive astrocytes in viral infections of the human brain express endothelin-like immunoreactivity. J Neurol Sci 126:184–192

    PubMed  CAS  Google Scholar 

  • Maguire J, Davenport AP (2004) Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels. J Cardiovasc Pharmacol 44Suppl 1:S27–29

    PubMed  CAS  Google Scholar 

  • Maguire J, Davenport AP (2005) Regulation of vascular reactivity by established and emerging GPC receptors. Trends Pharmacol Sci 26:448–454

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Davenport AP (1995) ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 115:191–197

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Davenport AP (1998a) Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol 125:238–240

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Davenport AP (1998b) PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts. J Cardiovasc Pharmacol 31Suppl 1:S239–240

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Davenport AP (2002) Is urotensin-II the new endothelin? Br J Pharmacol 137:579–588

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Kuc RE, O’Reilly G, Davenport AP (1994) Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol 113:49–54

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Kuc RE, Davenport AP (1997a) Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. J Pharmacol Exp Ther 280:1102–1108

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Johnson CM, Mockridge JW, Davenport AP (1997b) Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol 122:1647–1654

    PubMed  CAS  Google Scholar 

  • Maguire JJ, Ahn K, Davenport AP (1999) Inhibition of big endothelin-1 (BIG ET-1) responses in endothelium-denuded human coronary artery by the selective endothelin-converting enzyme-1 (ECE-1) inhibitor PD159790. Br J Clin Pharmacol 126:193P

    Google Scholar 

  • Maguire JJ, Kuc RE, Davenport AP (2001) Vasoconstrictor activity of novel endothelin peptide, ET-1(1–31), in human mammary and coronary arteries in vitro. Br J Pharmacol 134:1360–1366

    PubMed  CAS  Google Scholar 

  • Marciniak SJ, Plumpton C, Barker PJ, Huskisson NS, Davenport AP (1992) Localization of immunoreactive endothelin and proendothelin in the human lung. Pulm Pharmacol 5:175–182

    PubMed  CAS  Google Scholar 

  • Matsumoto H, Suzuki N, Kitada C, Fujino M (1994) Endothelin family peptides in human plasma and urine: their molecular forms and concentrations. Peptides 15:505–510

    PubMed  CAS  Google Scholar 

  • McCulloch KM, Docherty CC, Morecroft I, MacLean MR (1996) EndothelinB receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol 119:1125–1130

    PubMed  CAS  Google Scholar 

  • McKay KO, Black JL, Diment LM, Armour CL (1991) Functional and autoradiographic studies of endothelin-1 and endothelin-2 in human bronchi, pulmonary arteries, and airway parasympathetic ganglia. J Cardiovasc Pharmacol 17Suppl 7:S206–209

    PubMed  CAS  Google Scholar 

  • Migdalis IN, Kalogeropoulou K, Iiopoulou V, Varvarigos N, Karmaniolas KD, Mortzos G, Cordopatis P (2000) Progression of carotid atherosclerosis and the role of endothelin in diabetic patients. Res Commun Mol Pathol Pharmacol 108:27–37

    PubMed  CAS  Google Scholar 

  • Minami S, Yamano S, Yamamoto Y, Sasaki R, Nakashima T, Takaoka M, Hashimoto T (2001) Associations of plasma endothelin concentration with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension. Hypertens Res 24:663–670

    PubMed  CAS  Google Scholar 

  • Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, Yazaki Y (1997) Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 95:221–230

    PubMed  CAS  Google Scholar 

  • Miyamoto Y, Yoshimasa T, Arai H, Takaya K, Ogawa Y, Itoh H, Nakao K (1996) Alternative RNA splicing of the human endothelin-A receptor generates multiple transcripts. Biochem J 313:795–801

    PubMed  CAS  Google Scholar 

  • Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, Masaki T, de Wit D, Yanagisawa M, Kimura S (1997) Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 120:1427–1430

    PubMed  CAS  Google Scholar 

  • Mockridge JW, Kuc RE, Huskisson NS, Barker PJ, Davenport AP (1998) Characterization of site-directed antisera against endothelin-converting enzymes. J Cardiovasc Pharmacol 31Suppl 1:S35–37

    PubMed  CAS  Google Scholar 

  • Molenaar P, Kuc RE, Davenport AP (1992) Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol 107:637–639

    PubMed  CAS  Google Scholar 

  • Molenaar P, O’Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538

    PubMed  CAS  Google Scholar 

  • Mombouli JV, Le SQ, Wasserstrum N, Vanhoutte PM (1993) Endothelins 1 and 3 and big endothelin-1 contract isolated human placental veins. J Cardiovasc Pharmacol 22Suppl 8:S278–281

    PubMed  CAS  Google Scholar 

  • Moravec CS, Reynolds EE, Stewart RW, Bond M (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159:14–18

    PubMed  CAS  Google Scholar 

  • Morton AJ, Davenport AP (1992) Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res 581:299–306

    PubMed  CAS  Google Scholar 

  • Münter K, Hergenröder S, Unger L, Kirchengast M (1996) Oral treatment with an ETA receptor antagonist inhibits neointima formation induced endothelial injury. Pharm Pharmacol Lett 6:90–92

    Google Scholar 

  • Nakamuta M, Takayanagi R, Sakai Y, Sakamoto S, Hagiwara H, Mizuno T, Saito Y, Hirose S, Yamamoto M, Nawata H (1991) Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochem Biophys Res Commun 177:34–39

    PubMed  CAS  Google Scholar 

  • Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H (1997) Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol 159:1987–1992

    PubMed  CAS  Google Scholar 

  • Nakov R, Pfarr E, Eberle S (2002) Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension. Am J Hypertens 15:583–589

    PubMed  CAS  Google Scholar 

  • Nambi P, Pullen M, Wu HL, Aiyar N, Ohlstein EH, Edwards RM (1992) Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131:1081–1086

    PubMed  CAS  Google Scholar 

  • Nilsson T, Cantera L, Adner M, Edvinsson L (1997) Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 40:346–351; discussion 351–353

    PubMed  CAS  Google Scholar 

  • O’Reilly G, Charnock-Jones DS, Davenport AP, Cameron IT, Smith SK (1992) Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab 75:1545–1549

    PubMed  CAS  Google Scholar 

  • O’Reilly G, Charnock-Jones DS, Morrison JJ, Cameron IT, Davenport AP, Smith SK (1993) Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun 193:834–840

    PubMed  CAS  Google Scholar 

  • Ohlstein EH, Nambi P, Hay DW, Gellai M, Brooks DP, Luengo J, Xiang JN, Elliott JD (1998) Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist. J Pharmacol Exp Ther 286:650–656

    PubMed  CAS  Google Scholar 

  • Opgenorth TJ, Adler AL, Calzadilla SV, Chiou WJ, Dayton BD, Dixon DB, Gehrke LJ, Hernandez L, Magnuson SR, Marsh KC, Novosad EI, Von Geldern TW, Wessale JL, Winn M, Wu-Wong JR (1996) Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. J Pharmacol Exp Ther 276:473–481

    PubMed  CAS  Google Scholar 

  • Papadopoulos SM, Gilbert LL, Webb RC, D’Amato CJ (1990) Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery 26:810–815

    PubMed  CAS  Google Scholar 

  • Perfetto F, Tarquini R, Tapparini L, Tarquini B (1998) Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis. J Diabetes Complications 12:187–192

    PubMed  CAS  Google Scholar 

  • Pernow J, Kaijser L, Lundberg JM, Ahlborg G (1996) Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans. Circulation 94:2077–2082

    PubMed  CAS  Google Scholar 

  • Peter MG, Davenport AP (1995) Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart. Br J Pharmacol 114:297–302

    PubMed  CAS  Google Scholar 

  • Peter MG, Davenport AP (1996) Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol 117:455–462

    PubMed  CAS  Google Scholar 

  • Pierre LN, Davenport AP (1995) Autoradiographic study of endothelin receptors in human cerebral arteries. J Cardiovasc Pharmacol 26Suppl 3:S326–328

    PubMed  CAS  Google Scholar 

  • Pierre LN, Davenport AP (1998a) Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J Cardiovasc Pharmacol 31Suppl 1:S74–76

    PubMed  CAS  Google Scholar 

  • Pierre LN, Davenport AP (1998b) Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol 124:499–506

    PubMed  CAS  Google Scholar 

  • Pierre LN, Davenport AP (1999) Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke 30:638–643

    PubMed  CAS  Google Scholar 

  • Plumpton C, Champeney R, Ashby MJ, Kuc RE, Davenport AP (1993) Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J Cardiovasc Pharmacol 22Suppl 8:S26–28

    PubMed  CAS  Google Scholar 

  • Plumpton C, Haynes WG, Webb DJ, Davenport AP (1995) Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol 116:1821–1828

    PubMed  CAS  Google Scholar 

  • Plumpton C, Ashby MJ, Kuc RE, O’Reilly G, Davenport AP (1996a) Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) 90:37–46

    PubMed  CAS  Google Scholar 

  • Plumpton C, Ferro CJ, Haynes WG, Webb DJ, Davenport AP (1996b) The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol 119:311–314

    PubMed  CAS  Google Scholar 

  • Purkiss JR, West D, Wilkes LC, Scott C, Yarrow P, Wilkinson GF, Boarder MR (1994) Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists. Br J Pharmacol 111:1041–1046

    PubMed  CAS  Google Scholar 

  • Raschack M, Unger L, Riechers H, Klinge D (1995) Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death. J Cardiovasc Pharmacol 26Suppl 3:S397–399

    PubMed  CAS  Google Scholar 

  • Riezebos J, Watts IS, Vallance PJ (1994) Endothelin receptors mediating functional responses in human small arteries and veins. Br J Pharmacol 111:609–615

    PubMed  CAS  Google Scholar 

  • Rizzi A, Calo G, Battistini B, Regoli D (1998) Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities. J Cardiovasc Pharmacol 31Suppl 1:S58–61

    PubMed  CAS  Google Scholar 

  • Rossi GP, Albertin G, Franchin E, Sacchetto A, Cesari M, Palu G, Pessina AC (1995) Expression of the endothelin-converting enzyme gene in human tissues. Biochem Biophys Res Commun 211:249–253

    PubMed  CAS  Google Scholar 

  • Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G (2002) Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896–903

    PubMed  CAS  Google Scholar 

  • Russell FD, Davenport AP (1995) Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139. J Cardiovasc Pharmacol 26Suppl 3:S346–347

    PubMed  CAS  Google Scholar 

  • Russell FD, Davenport AP (1996) Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol 119:631–636

    PubMed  CAS  Google Scholar 

  • Russell FD, Davenport AP (1999a) Secretory pathways in endothelin synthesis. Br J Pharmacol 126:391–398

    PubMed  CAS  Google Scholar 

  • Russell FD, Davenport AP (1999b) Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res 84:891–896

    PubMed  CAS  Google Scholar 

  • Russell FD, Skepper JN, Davenport AP (1997) Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol 29:820–826

    PubMed  CAS  Google Scholar 

  • Russell FD, Skepper JN, Davenport AP (1998a) Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83:314–321

    PubMed  CAS  Google Scholar 

  • Russell FD, Skepper JN, Davenport AP (1998b) Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol 31:424–430

    PubMed  CAS  Google Scholar 

  • Russell FD, Skepper JN, Davenport AP (1998c) Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol 31Suppl 1:S19–S21

    PubMed  CAS  Google Scholar 

  • Saeki T, Ihara M, Fukuroda T, Yamagiwa M, Yano M (1991) [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity. Biochem Biophys Res Commun 179:286–292

    PubMed  CAS  Google Scholar 

  • Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735

    PubMed  CAS  Google Scholar 

  • Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Loffler BM (1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328:871–877

    PubMed  CAS  Google Scholar 

  • Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF (1994) Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203–1208

    PubMed  CAS  Google Scholar 

  • Shimada K, Matsushita Y, Wakabayashi K, Takahashi M, Matsubara A, Iijima Y, Tanzawa K (1995a) Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun 207:807–812

    PubMed  CAS  Google Scholar 

  • Shimada K, Takahashi M, Ikeda M, Tanzawa K (1995b) Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett 371:140–144

    PubMed  CAS  Google Scholar 

  • Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G, Tapson VF, Rubin LJ (2003) Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest 124:247–254

    PubMed  CAS  Google Scholar 

  • Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, Fourme T, Humbert M, Delfraissy JF, Simonneau G (2004) Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 170:1212–1217

    PubMed  Google Scholar 

  • Spatz M, Kawai N, Merkel N, Bembry J, McCarron RM (1997) Functional properties of cultured endothelial cells derived from large microvessels of human brain. Am J Physiol 272:C231–239

    PubMed  CAS  Google Scholar 

  • Stanimirovic DB, Yamamoto T, Uematsu S, Spatz M (1994) Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem 62:592–601

    PubMed  CAS  Google Scholar 

  • Stein PD, Hunt JT, Floyd DM, Moreland S, Dickinson KE, Mitchell C, Liu EC, Webb ML, Murugesan N, Dickey J, et al (1994) The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide. J Med Chem 37:329–331

    PubMed  CAS  Google Scholar 

  • Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O’Halloran DJ, Bloom SR (1991) Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 72:693–699

    PubMed  CAS  Google Scholar 

  • Takahashi M, Matsushita Y, Iijima Y, Tanzawa K (1993) Purification and characterization of endothelin-converting enzyme from rat lung. J Biol Chem 268:21394–21398

    PubMed  CAS  Google Scholar 

  • Takahashi M, Fukuda K, Shimada K, Barnes K, Turner AJ, Ikeda M, Koike H, Yamamoto Y, Tanzawa K (1995) Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem J 311:657–665

    PubMed  CAS  Google Scholar 

  • Takahashi T, Barnes PJ, Kawikova I, Yacoub MH, Warner TD, Belvisi MG (1997) Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan. Eur J Pharmacol 324:219–222

    PubMed  CAS  Google Scholar 

  • Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, Urade Y, Inui T, Yamamura T, Okada T (1992) A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun 184:953–959

    PubMed  CAS  Google Scholar 

  • Takai S, Jin D, Sakaguchi M, Miyazaki M (1999) Chymase-dependent angiotensin II formation in human vascular tissue. Circulation 100:654–658

    PubMed  CAS  Google Scholar 

  • Takeji T, Nakaya Y, Kamada M, Maeda K, Saijo Y, Mitani R, Irahara M, Aono T (2000) Effect of a novel vasoconstrictor endothelin-1 (1-31) on human umbilical artery. Biochem Biophys Res Commun 270:622–624

    PubMed  CAS  Google Scholar 

  • Tanaka H, Moroi K, Iwai J, Takahashi H, Ohnuma N, Hori S, Takimoto M, Nishiyama M, Masaki T, Yanagisawa M, Sekiya S, Kimura S (1998) Novel mutations of the endothelin B receptor gene in patients with Hirschsprung’s disease and their characterization. J Biol Chem 273:11378–11383

    PubMed  CAS  Google Scholar 

  • Tanaka T, Tsukuda E, Nozawa M, Nonaka H, Ohno T, Kase H, Yamada K, Matsuda Y (1994) RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol 45:724–730

    PubMed  CAS  Google Scholar 

  • Taylor TA, Gariepy CE, Pollock DM, Pollock JS (2003) Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet. Hypertension 41:657–662

    PubMed  CAS  Google Scholar 

  • Thorin E, Nguyen TD, Bouthillier A (1998) Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke 29:175–180

    PubMed  CAS  Google Scholar 

  • Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G (1993) Endothelin is released from the porcine coronary circulation after short-term ischemia. J Cardiovasc Pharmacol 22Suppl 8:S313–316

    PubMed  Google Scholar 

  • Turner AJ, Murphy LJ (1996) Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51:91–102

    PubMed  CAS  Google Scholar 

  • Turner AJ, Barnes K, Schweizer A, Valdenaire O (1998) Isoforms of endothelin-converting enzyme: why and where? Trends Pharmacol Sci 19:483–486

    PubMed  CAS  Google Scholar 

  • Valdenaire O, Rohrbacher E, Mattei MG (1995) Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270:29794–29798

    PubMed  CAS  Google Scholar 

  • Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB (1999) A fourth isoformof endothelin-converting enzyme(ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264:341–349

    PubMed  CAS  Google Scholar 

  • Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ (1998) Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97:752–756

    PubMed  CAS  Google Scholar 

  • Vierhapper H, Wagner O, Nowotny P, Waldhausl W (1990) Effect of endothelin-1 in man. Circulation 81:1415–1418

    PubMed  CAS  Google Scholar 

  • von Geldern TW, Tasker AS, Sorensen BK, Winn M, Szczepankiewicz BG, Dixon DB, Chiou WJ, Wang L, Wessale JL, Adler A, Marsh KC, Nguyen B, Opgenorth TJ (1999) Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity. J Med Chem 42:3668–3678

    Google Scholar 

  • Watakabe T, Urade Y, Takai M, Umemura I, Okada T (1992) A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8-21), [125I]IRL1620. Biochem Biophys Res Commun 185:867–873

    PubMed  CAS  Google Scholar 

  • Waxman L, Doshi KP, Gaul SL, Wang S, Bednar RA, Stern AM (1994) Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme. Arch Biochem Biophys 308:240–253

    PubMed  CAS  Google Scholar 

  • Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV (1991) Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556–561

    PubMed  CAS  Google Scholar 

  • Williams DL Jr, Murphy KL, Nolan NA, O’Brien JA, Pettibone DJ, Kivlighn SD, Krause SM, Lis EV Jr, Zingaro GJ, Gabel RA, et al (1995) Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist. J Pharmacol Exp Ther 275:1518–1526

    PubMed  CAS  Google Scholar 

  • Winkles JA, Alberts GF, Brogi E, Libby P (1993) Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 191:1081–1088

    PubMed  CAS  Google Scholar 

  • Wu C, Chan MF, Stavros F, Raju B, Okun I, Mong S, Keller KM, Brock T, Kogan TP, Dixon RA (1997) Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J Med Chem 40:1690–1697

    PubMed  CAS  Google Scholar 

  • Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473–485

    PubMed  CAS  Google Scholar 

  • Yamaga S, Tsutsumi K, Niwa M, Kitagawa N, Anda T, Himeno A, Khalid H, Taniyama K, Shibata S (1995) Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography. Cell Mol Neurobiol 15:327–340

    PubMed  CAS  Google Scholar 

  • Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, de Wit D, Emoto N, Hammer RE (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825–836

    PubMed  CAS  Google Scholar 

  • Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda S, Clouthier DE, Yanagisawa M (2000) Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105:1373–1382

    PubMed  CAS  Google Scholar 

  • Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) Anovel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    PubMed  CAS  Google Scholar 

  • Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, Hamada T, Otani S, Yanagisawa M, Takeda T (1991) Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 114:213–215

    PubMed  CAS  Google Scholar 

  • Yu JC, Pickard JD, Davenport AP (1995) Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol 116:2441–2446

    PubMed  CAS  Google Scholar 

  • Zhang M, Olsson Y (1995) Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells. J Neurol Sci 134:26–32

    PubMed  CAS  Google Scholar 

  • Zhang YF, Jeffery S, Burchill SA, Berry PA, Kaski JC, Carter ND (1998) Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. Br J Cancer 78:1141–1146

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 2QQ, UK

    A. P. Davenport & J. J. Maguire

Authors
  1. A. P. Davenport
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. J. Maguire
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. P. Davenport .

Editor information

Editors and Affiliations

  1. The Wolfson Institute for Biomedical Research, University College London, Gower Street, London, WC1E 6BT, UK

    Salvador Moncada FRCP FRS  & Annie Higgs  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Davenport, A.P., Maguire, J.J. (2006). Endothelin. In: Moncada, S., Higgs, A. (eds) The Vascular Endothelium I. Handbook of Experimental Pharmacology, vol 176/I. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-32967-6_9

Download citation

Publish with us

Policies and ethics

Search

Navigation